Background information. The idea that GPCRs (G-protein-coupled receptors) may exist as homo-or heterooligomers, although still controversial, is now widely accepted. Nevertheless, the functional roles of oligomerization are still unclear and gaining greater insight into the mechanisms underlying the dynamics of GPCR assembly and, in particular, assessing the effect of ligands on this process seems important. We chose to focus our present study on the effect of MT7 (muscarinic toxin 7), a highly selective allosteric peptide ligand, on the oligomerization state of the hM 1 (human M 1 muscarinic acetylcholine receptor subtype).
Introduction
GPCRs (G-protein-coupled receptors) are the largest family of signalling proteins in mammals and the target of approximately half of the drugs commercially available today (Drews, 2000) , explaining why their structural and functional properties are being extensively studied. Although a monomeric GPCR can be functional (Chabre et al., 2003; Chabre and le Maire, 2005; Whorton et al., 2007) , there is now a consensus that some GPCRs can exist in dimeric or oligomeric forms. However, several aspects of this association are still under debate, such as its permanence (the 'kiss-and-run' problem) (Gurevich and Gurevich, 2008) or its roles in addressing, signalling or recycling of the receptor (Bulenger et al., 2005; Gurevich and Gurevich, 2008; Milligan, 2007; Terrillon and Bouvier, 2004) . In this context, understanding the mechanisms underlying the dynamics and regulation of GPCR assembly is of the utmost importance, and assessing the effect of ligands on this dimerization process is a promising approach.
mAChRs [muscarinic ACh (acetylcholine) receptors] are members of the class A group of GPCRs. The five subtypes of mAChRs, which play crucial roles in the neuronal and non-neuronal cholinergic function, display specific location, distinct pharmacological properties and are associated with various cognitive, respiratory or genito-urinary disorders (Eglen, 2006; Wess et al., 2007) . The dimerization of muscarinic receptors has been described previously using both biochemical (Park and Wells, 2003; Zeng and Wess, 1999) and biophysical techniques (Goin and Nathanson, 2006) . Goin and Nathanson (2006) showed, using BRET (bioluminescence resonance energy transfer) assays, that the M 1 , M 2 and M 3 subtypes of the mAChR were present in cells under different oligomeric forms, the dimeric one being predominant.
The effect of ligands on mAChR oligomerization was also assessed. Two kinds of ligands, orthosteric and allosteric, can bind to these receptors. Orthosteric ligands, i.e. the endogenous agonist (ACh), competitive agonists and antagonists, bind in a pocket nested in the core of the transmembrane domains (Goodwin et al., 2007; Hulme et al., 2003) . Allosteric ligands can modulate the binding kinetics of orthosteric ligands and bind to one or several sites (Lazareno et al., 2000) , located more extracellularly. Whereas carbachol, an orthosteric agonist, does not seem to have an effect on M 1 , M 2 and M 3 dimerization (Goin and Nathanson, 2006; Zeng and Wess, 1999) , QNB (quinuclydinyl benzylate) and pirenzepine, as orthosteric antagonists, were reported to have a stabilizing effect on M 2 oligomerization (Park and Wells, 2003) and a promoting effect on M 1 dimerization (Ilien et al., 2009) respectively.
Interestingly, for other GPCRs, agonists were described as having an increasing, decreasing or no effect on oligomerization, depending on the receptor studied (reviewed in Pfleger and Eidne, 2005) . More recently, a study on β2-adrenoreceptors showed that agonists and neutral antagonists have little effect on receptor oligomerization, whereas an inverse agonist promotes rearrangement of the receptor protomers and/or the formation of higher-order oligomers (Fung et al., 2009) . It thus seems that no general tendency regarding the effects of ligands on GPCR oligomerization can be drawn from the experimental data available today and that this effect should be studied on a case-by-case basis. In addition, the earlier (Palczewski et al., 2000) and the recent crystallographic (Cherezov et al., 2007; Jaakola et al., 2008; Park et al., 2008; Scheerer et al., 2008; Warne et al., 2008) structures of GPCRs, although extremely useful for other aspects, provide no conclusive evidence on this subject.
Muscarinic toxins are the only ligands displaying high selectivity for the different subtypes of mAChRs (Bradley, 2000; Karlsson et al., 2000; Servent and Fruchart-Gaillard, 2009 ). These peptides of 64-65 residues, presenting a three-fingerfold structure, were initially isolated from the venom of mambas. MT7 (muscarinic toxin 7) toxin is particularly interesting, with its subnanomolar affinity for the M 1 receptor subtype, associated with an exquisite selectivity (Max et al., 1993a; Mourier et al., 2003) . MT7 has been described as an allosteric modulator with antagonist functional properties (Max et al., 1993b; Olianas et al., 2000; FruchartGaillard et al., 2006 FruchartGaillard et al., , 2008 .
In the present study, the degree of oligomerization of the hM 1 (human M 1 muscarinic ACh receptor subtype) receptor expressed in different cell lines and the effect of MT7 on the receptor status were examined using: (i) Western blotting and autoradiographic analyses of native gel electrophoresis performed on solubilized cell membranes; (ii) hetero-FRET (fluorescence resonance energy transfer) signal measurement, following acceptor photobleaching of cells co-transfected with cDNAs encoding two different fluorescently tagged hM 1 receptors; (iii) homo-FRET fluorescence emission and anisotropy ratio calculation after transient transfection of cells with cDNAs encoding EGFP-hM 1 (enhanced green fluorescent protein-hM 1 ); and, finally, (iv) BRET assays between hM 1 -RLuc (hM 1 -Renilla luciferase) and hM 1 -EYFP (hM 1 -enhanced yellow fluorescent protein). All these complementary techniques support the hypothesis of an interaction of MT7 with a dimeric form of the hM 1 receptor. 
Results

Native-PAGE of solubilized CHO-M1 membranes incubated with or without MT7 and analysed by Western blotting and autoradiography
We investigated the effect of MT7 on the different hM 1 oligomerization forms obtained after membrane solubilization, using a double staining technique that is specific for either the receptor or the toxin. First, we investigated the effect of pre-incubation of the membranes of CHO cells stably expressing the hM 1 receptor with increasing MT7 concentrations (from 150 pM to 1.5 μM). After solubilization in 1% DDM (n-dodecyl-β-D-maltoside), native-PAGE and transfer on to a PVDF membrane, Western blotting analysis was performed using an antibody directed against the hM 1 receptor ( Figure 1A ). In the absence of MT7, one band at approx. 60 kDa, consistent with a monomeric form of the hM 1 receptor, was observed. On the other hand, in the presence of increasing concentrations of MT7, the band migrating at 60 kDa disappeared progressively and a band at approx. 140 kDa, consistent with a dimeric form of hM 1 , became predominant with MT7 concentrations from 15 nM. In addition, to evaluate the specificity of the MT7 effect as compared with other ligands, membranes of CHO-M1 cells (Chinese-hamster ovary cells expressing muscarinic M 1 receptors) were preincubated with MT7, MT3, the agonist ACh or the antagonist NMS (N-methylscopolamine). Whereas 15 nM MT7 induced a shift of the hM 1 receptor molecular mass from 60 to 140 kDa, the same concentration of the structurally identical and low-M 1 -interactive MT3 toxin had no effect ( Figure 1B ). Furthermore, incubation with ACh (1 mM) did not affect the M 1 receptor state, whereas, with 100 nM of NMS, both putative monomeric and dimeric forms of the receptor are present ( Figure 1B ). In order to be able to detect the hM 1 -MT7 complex via the toxin, a low concentration of iodinated MT7 (15 pM [ 125 I]MT7) was incubated with the CHO-M1 membranes and the blot was revealed by autoradiography with a β-imager. Simultaneously, the same gel was also analysed by Western blotting. In agreement with the results shown in Figure 1 (A), with 15 pM MT7 the only band detected by immunostaining of the receptor corresponded to a monomeric form ( Figure 1D) ; nevertheless, as shown on the autoradiograph ( Figure 1C) , the radioactivity associated with the binding of [
125 I]MT7 on the hM 1 is only present on the band, consistent with a dimeric state for a small fraction of the hM 1 receptor. This binding is specific, as it was totally abolished in the presence of a large excess of non-radioactive MT7 ( Figure 1C) . The large band at 20 kDa revealed by autoradiography corresponded to free iodinated MT7 released from the receptor after the solubilization step. Finally, the same experiment was performed with membranes of CHO cells expressing the hM 3 receptor subtype. In this case, no radioactivity was detected in the presence of [
125 I]MT7, confirming the specificity of the effect on the hM 1 receptor subtype ( Figure 1C ).
Acceptor-photobleaching experiments
To pursue the study of the effect of MT7 on the hM 1 oligomerization state in its native membrane environment, we then used two different biophysical FRET techniques. We first performed classical acceptor-photobleaching experiments using two hM 1 constructs. The first construct, named EGFP-hM 1 , was an hM 1 receptor with EGFP on its N-terminal part. The other one, named FLAG-hM 1 , was an hM 1 receptor with a His 6 tag and a FLAG tag on its C-and N-terminal parts respectively. Both receptors showed similar pharmacological properties to wild-type hM 1 regarding both [ 3 H]QNB (Weill et al., 1999 ) and MT7 binding (Table 1) and displayed a plasma membrane localization mainly when transiently transfected in tsA201 cells, as visualized by confocal microscopy (data not shown).
In the acceptor-photobleaching experiments (Bastiaens et al., 1996) , tsA201 cells co-expressing the EGFP-hM 1 and FLAG-hM 1 receptors were stained with an anti-FLAG antibody conjugated to a Cy3.5 (indocarbocyanine 3.5) fluorophore. In these experiments, if there is a FRET signal, showing spatial proximity between the donor and acceptor molecules, photobleaching the acceptor (Cy3.5) should result in a gain in donor (EGFP) fluorescence intensity ( Figure 2A ). Whereas no FRET signal was detected in cells expressing donor only (data not shown), in cells co-expressing the EGFP-hM 1 and FLAG-hM 1 receptors and immunostained with an anti-FLAG antibody conjugated to a Cy3.5 fluorophore, 18.5 + − 1.8% of the plasma membrane ROIs (regions of interest) displaying more than 20% acceptor photobleaching showed more than 5% FRET ( Figure 2B ) (false-positive FRET in cells without acceptor was less than 2%). Interestingly, after pre-incubation with MT7, the number of ROIs displaying more than 20% acceptor photobleaching and more than 5% FRET reached 27 + − 1.6% (Figure 2B ). Thus we show that incubation with MT7, which apparently favours the oligomeric forms of hM 1 , leads to a statistically significant 46% increase in the surface showing FRET (P = 0.0008, t test), consistent with increased proximity between EGFP and FLAG-Cy3.5. These results were based on the analysis of 20 ROIs/cell on eight cells in two independent experiments.
Fluorescence anisotropy experiments
In a distinctive approach, we imaged the emission fluorescence anisotropy of EGFP-hM 1 receptors expressed at the surface of living tsA201 cells. When homo-FRET occurs between EGFPs, the emission fluorescence anisotropy is reduced (Gautier Lidke et al., 2003) . We observed that tsA201 cells expressing EGFP-hM 1 showed lower fluorescence anisotropy when pre-incubated with MT7 ( Figure 3) . A typical experiment analysing 50 cells in detail (with or without MT7 treatment, 10 ROIs/cell) is shown in Figure 3 (A). Cells expressing EGFP-hM 1 displayed a mean anisotropy value of 0.1338 + − 0.0006, whereas, after preincubation with MT7, this mean value shifted to 0.1243 + − 0.0006, indicating a statistically significant shift towards lower anisotropy values after incubation with MT7 (for means, P < 0.0001, t test; for distribution, P = 0.0009, χ 2 test). This shift towards low fluorescence anisotropy values in the presence of MT7 was repeatably observed, as shown in Figure 3 (B) which represents the mean of the cumulated frequencies of three independent experiments (P < 0.0001, χ 2 test). Figure 3 (C) represents both the intensity image and a pixel-by-pixel map of anisotropy of typical tsA201 cells expressing EGFP-hM 1 in the presence or absence of MT7. The proportion of green pixels, which stand for low anisotropy values (0.10 < r < 0.12), is more important in the presence of MT7 as compared with control samples. Blue pixels, which represent very low anisotropy values (r < 0.10), are only visible after pre-incubation with MT7. These results indicate that MT7 incubation leads to an increase in homo-FRET between EGFP-hM 1 receptors, which would arise from oligomerization or conformational changes of oligomers.
BRET assays
BRET is a naturally occurring phenomenon resulting from the non-radiative transfer of energy between a luminescent donor and a fluorescent acceptor. Thus, in order to determine whether the hM 1 receptor can form homodimers in live COS cells, this receptor was fused at its C-terminus to the energy donor RLuc or to the acceptor EYFP. The pharmacological properties of these fused receptors were checked by examining in competition binding experiments their ability to interact with NMS or MT7. As reported in Table 1 , the affinity constants of these two ligands are similar for the wild-type or the tagged hM 1 receptors, justifying the use in BRET experiments of these receptor constructs to study the effect of these ligands.
A BRET saturation curve was first performed by co-expressing the hM 1 -RLuc at a constant concentration with increasing amounts of the EYFPtagged receptor. If the energy transfer is due to specific receptor-receptor interactions, the BRET signal will saturate, whereas a quasi-linear relationship will be associated with random collisions. As shown in Figure 4 , the BRET signal increased with the concentration of the acceptor before reaching an asymptote corresponding to the saturation of all BRET donors by acceptor molecules. The specificity of this BRET signal was supported by the very low signal Table) is indicated on the right and corresponds to anisotropy values ranging from 0.05 to 0.20. measured in the presence of both the hM 1 -RLuc and the unrelated GABA B R2-YFP (γ-aminobutyric acid B receptor subunit 2-YFP). In addition, coexpression of hM 1 -RLuc with soluble YFP led to marginal signals that increased linearly with the quantity of YFP added. These results suggest that some constitutive hM 1 homodimers exist in live COS cells. Furthermore, to assess the effect of various ligands on the BRET signal, we performed a BRET titration experiment in the presence of a saturating concentration of the allosteric modulator MT7 (100 nM), the competitive antagonist NMS (400 nM) and the agonist ACh (50 μM). The addition of MT7 and NMS increased the maximum BRET signal by 12 + − 2% and 18 + − 3% respectively, whereas ACh induces only a very weak increase in the net BRET (4 + − 1.6%) (mean value calculated at BRET max and similar fluorescence over luminescence ratio from three experiments and relative to the control experiment without ligand). In these experiments, neither the shape of the curves nor the concentration of the hM 1 -EYFP receptor needed to reach 50% of the maximal BRET signal (BRET 50 ) were affected (Figure 4 ).
Discussion
The dimerization of muscarinic receptors has been studied previously using either Western blot analysis of membrane preparations (Park and Wells, 2003; Zeng and Wess, 1999) or fluorescence studies on living cells (Goin and Nathanson, 2006; Ilien et al., 2009 Figure 1A ). The MT7 effect is not related solely to its three-dimensional structure, as an identical concentration of the MT3 toxin, which possesses the same three-finger-fold structure and interacts with very low affinity on the M 1 receptor, does not affect the oligomerization state of the M 1 receptor. Furthermore, an excess of a small antagonist, such as NMS, induces an effect similar to that of MT7, unlike the agonist ACh that does not modify the oligomerization status of the receptor, even at 1 mM ( Figure 1B) . Thus, despite the strong dissociating effect of detergent, MT7 at high concentration seems to promote or stabilize a putative dimeric form of the hM 1 receptor, the form to which iodinated MT7 bound preferentially ( Figure 1C ). It is interesting to note that the high sensitivity of the β-imager allows detection of a very low amount of the MT7-dimeric hM 1 complex which is not visualized by Western blotting. The low proportion of [ 125 I]MT7 bound on the solubilized receptor is probably due to the DDM treatment that affects drastically the toxin-receptor interaction.
To go further in this study and analyse the potential regulation of the hM 1 oligomerization in cells, we performed two different FRET experiments measuring, on one hand, hetero-FRET signals after acceptor photobleaching and, on the other hand, fluorescence anisotropy variations resulting from homo-FRET. Interestingly, we showed by acceptor-photobleaching experiments that there was already FRET occurring in the absence of ligand, possibly resulting from the presence of some constitutive oligomeric forms of hM 1 receptor, in accordance with previous results (Goin and Nathanson, 2006) . Nevertheless, this observation does not exclude the presence of monomeric receptors in our cells and the percentage of the respective oligomeric forms is unknown. Our results showed, in both cases, that incubation with MT7 led to a higher FRET signal, revealed either by an increase in donor fluorescence after acceptor photobleaching ( Figure 2B ) or by a significant decrease in fluorescence anisotropy ( Figure 3 ). This FRET enhancement can be due to an increase in hM 1 oligomer formation or to conformational changes associated with modifications of the distance/orientation between the donor and acceptor within the dimers.
Whereas acceptor-photobleaching experiments necessitate initial fixation of the cells which possibly disturbs the receptor, this is not the case for either BRET or the emission fluorescence anisotropy methodologies. Moreover, the latter strategy requires the expression of only one fluorescent derivative, and is independent of fluorescence intensity and fluorophore concentration; it is thus a powerful technique to study the oligomerization of GPCRs.
BRET methodology was also used to, firstly, evaluate the ability of MT7 to interact with a dimeric hM 1 receptor and, secondly, to explore how MT7 may affect these dimers. Indeed, analyses of BRET saturation curves and, in particular, of the variations in the maximal BRET level and BRET 50 value induced by ligands can reflect how these affect the dimerization process (Mercier et al., 2002; Percherancier et al., 2005; Audet et al., 2008) . In our present study, BRET saturation curves of the control experiment confirm the presence of some native hM 1 homodimers in living cells, as described previously (Goin and Nathanson, 2006) . The hyperbolic and saturating nature of this BRET titration curve and the lack of significant BRET signal in the control experiments using either soluble YFP or the GABA B R2 receptor in co-expression with hM 1 -RLuc, reinforce the specificity of the constitutive hM 1 dimerization. The BRET titration experiment also highlights the capacity of MT7 and NMS to increase significantly the BRET max signal without affecting the BRET 50 . In opposition, as described previously for the carbachol (Goin and Nathanson, 2006) , ACh has no significant effect on the BRET max signal. Because modification of the BRET max signal without alteration of the BRET 50 value most likely reflects structural reorganization within the dimer, we can postulate that the MT7 treatment did not modify the number of dimers, but more probably affected the distance between the two hM 1 protomers by some unknown conformational changes.
Taken together, the results of these various biochemical and biophysical techniques all converge towards the idea that some hM 1 homodimers or oligomers exist constitutively in the different cell lines that we studied and that MT7 can bind to and may stabilize this dimeric form, probably by inducing some conformational rearrangement within the receptor dimers. The postulate that MT7 may interact with a dimeric form of the hM 1 receptor was reinforced by our knowledge, at the molecular level, on this interaction. In particular, the location of critical binding residues of the toxin spread over its three loops is compatible with a large interacting surface on an oligomeric form of the receptor (Fruchart-Gaillard et al., 2008) . Moreover, the structural model of this interaction, based on cycle-mutant analysis of MT7 and the hM 1 receptor that is under progress in our laboratory, is in agreement with this proposal (D. Servent, unpublished data).
In conclusion, MT7 interacts allosterically with the hM 1 muscarinic receptor, displays antagonist functional properties and can bind to a putative dimeric state of the hM 1 receptor, promoting its stability. The precise capacity of MT7 to recognize the various monomeric and oligomeric hM 1 receptors is still unknown and needs to be characterized more precisely before beginning to exploit the radioactive or fluorescent derivatives of MT7 to detect the different forms of hM 1 receptor at the cell surface.
Materials and methods
Receptor constructs
EGFP-hM 1 (ChimA2) and FLAG-hM 1 (MutE) receptors were provided by Dr B. Ilien (Institut de Recherche de l'Ecole de Biotechnologie de Strasbourg, Illkirch, France) and these constructs were precisely described in previous studies (Weill et al., 1999; Ilien et al., 2003; Tahtaoui et al., 2004) . hM 1 -EYFP and hM 1 -RLuc were constructed by ligating the coding sequence of the hM 1 receptor, after amplification by PCR, into pGFP-N1-Topaze (PerkinElmer Life and Analytical Sciences) and (hRLuc)-N3 (BioSignal) using the XhoI and AgeI or XhoI and HindIII sites respectively. In these fusion proteins, the fluorescence and luminescence moieties were located at the C-terminal end of the hM 1 receptor. The constructs were sequenced to ensure the absence of unwanted mutations.
Stable and transient mAChR expression
Professor P.O. Couraud [Institut Cochin de Génétique Moléculaire (ICGM), Paris, France] provided CHO cells stably expressing the cloned human muscarinic M 1 (15 pmol/mg of protein) and M 3 (1.4 pmol/mg of protein) receptors. The cells were grown in plastic Petri dishes (Falcon) which were incubated at 37
• C in an atmosphere of 5% CO 2 and 95% humidified air in Ham's F12 medium pre-supplemented with L-glutamine and bicarbonate, supplemented with 10% fetal calf serum, 1 μg/ml amphotericin B, and 1% penicillin/streptomycin. All products were from Sigma. Heterologous transient expression of EGFPhM 1 and FLAG-hM 1 were performed in tsA201 cells cultured in 10-cm-diameter tissue culture dishes (Falcon). tsA201 cells were incubated at 37
• C in an atmosphere of 5% CO 2 and 95% humidified air in MEM (modified Eagle's medium) supplemented with 10% fetal calf serum, 1 μg/ml amphotericin B, 1% L-glutamine and 1% penicillin/streptomycin. All products were from Sigma. At 100% confluence (CHO-hM1) or 3 days after transfection (COS and tsA201), cells were harvested using Versen buffer (PBS with 5 mM EDTA), washed with ice-cold phosphate buffer and centrifuged at 1700 g for 3 min (4
• C) three times. The pellet was stored at −20
• C. For membrane preparation, the cell pellet was suspended in ice-cold buffer (1 mM EDTA, 25 mM sodium phosphate and 5 mM MgCl 2 , pH 7.4) and homogenized using an Elvehjem-Potter homogenizer (Fisher Scientific Labosi, Elancourt, France). The homogenate was centrifuged at 1700 g for 15 min at 4
• C. The sediment was re-suspended in buffer, homogenized and centrifuged at 1700 g for 15 min at 4
• C. The combined supernatants were centrifuged at 35 000 g for 30 min at 4
• C and the pellet was suspended in the same buffer (0.1 ml/dish). Protein concentrations were determined according to the Lowry method using BSA as standard. Membrane preparations were aliquoted and stored at −80
• C.
Toxin synthesis, purification, mass determination, sequencing and CD analyses
Chemical synthesis, refolding and purification, as well as all the physico-chemical analysis of the muscarinic toxins, were performed as described previously (Mourier et al., 2003) .
Gel electrophoresis and Western blot analysis
To evaluate the dose-response effect of MT7, 10 μg of membrane preparations from CHO cell lines stably expressing the hM 1 receptor (7 μl of a 1.4 mg/ml solution corresponding to 150 fmol of ligand-binding sites) were first incubated overnight at 4
• C with increasing amount of MT7 (50 fmol to 500 nmol) in a total volume of 300 μl. The specificity of the MT7 effect was studied identically with high concentrations of MT3 (15 nM), ACh (1 mM) and NMS (100 nM). For autoradiographic analysis, 15 pM [ 125 I]MT7 alone or in the presence of a large excess of MT7 (150 nM) were pre-incubated with 10 μg of hM 1 membrane preparation. Then, for all these experiments, the incubation solutions were centrifuged at 15 000 g for 15 min at 4
• C. Pellets were suspended and concentrated ten times in solubilization buffer (10 mM Hepes, pH 7.4, 150 mM NaCl and 3.4 mM EDTA) supplemented with 1% DDM (Sigma). After an overnight incubation at 4
• C and a centrifugation at 15 000 g for 3 h at 4
• C, supernatant soluble fractions, representing 75% of the total proteins, were collected. G250 additive (0.5 μl; Invitrogen) and 4 μl of 4 × loading buffer were added to 7 μl of the supernatant and this solution was loaded on to NativePAGE TM Novex ® 3-12% Bis-Tris Gels (Invitrogen). After migration at room temperature (24
• C), proteins were transferred efficiently (45 min at 12 V) on to a PVDF membrane pre-wet for 30 s in methanol. After transfer, proteins were fixed in 8% acetic acid for 15 min. The presence of labelled [
125 I]MT7, free or associated with the hM 1 receptor, was detected using a β-Imager TM 2000 from Biospace (Paris, France) with acquisition performed at a low-resolution 125 I mode. In this gel, the resolution of low-molecular-mass protein is imprecise and MT7 (7 kDa) migrates with an apparent 20 kDa molecular mass. Then, on the same PVDF membrane, Western blotting was performed with a polyclonal antibody directed against hM 1 receptor (1:400 dilution; Alomone Labs, Jerusalem, Israel) followed by GAR-PO (horseradish-peroxidase-conjugated goat anti-rabbit immunoglobulin) antibody (1:200 000 dilution). The detection kit was ECL Advance Western Blotting (GE Healthcare, Velizy, France).
Binding experiments
All binding experiments were carried out at room temperature, in PBS-BSA (10 mM sodium phosphate, pH 7.2, 135 mM NaCl, 2.5 mM KCl, pH 7.4, and 0.1% BSA). ]NMS (0.5 nM) and varying concentrations of NMS or MT7, in a final assay volume of 300 μl. Non-specific binding was determined in the presence of 50 μM atropine. The reaction was stopped by the addition of 3 ml of ice-cold buffer (10 mM Tris), immediately followed by filtration through Whatman GF/C glass fibre filters, pre-soaked in 0.5% polyethylenimine. The filters were washed once with 3 ml of ice-cold buffer (PBS), dried and the bound radioactivity counted by liquid scintillation spectrometry. Each experiment was carried out at least three times.
The binding data from individual experiments were analysed by non-linear regression analysis using Kaleidagraph 4.0 (Synergy Software, Reading, PA, U.S.A.).
Acceptor photobleaching experiments
Before fixation (5 days), tsA201 cells were resuspended in Petri dishes containing 1-cm-diameter cover slips at 50% confluence. The following day, cells were co-transfected with cDNAs (7.5 μg of each) encoding EGFP-hM 1 and FLAG-hM 1 by the calcium phosphate technique (Chen and Okayama, 1987) . Before fixation (24 h), each cover slip was incubated overnight at 30
• C in the presence or absence of an excess of MT7 (60 nM). The next day, cells were fixed by a 10 min incubation at room temperature in 4% paraformaldehyde. Immunostaining was performed with a Cy3.5-conjugated anti-FLAG antibody (1:100 dilution), for 1 h, at room temperature, in the dark. All products were from Sigma. Samples were observed with a laser-scanning confocal microscope (Leica TCS SP2, Leica Microsystems, Nanterre, France) mounted on an upright microscope controlled through the software and workstation supplied by the manufacturer. Images were collected using an oil-immersion lens [40 × , NA (numerical aperture) 1.25]. A series of optical sections were collected using a standard scanning mode format of 1024 pixels × 1024 pixels. The 454 nm line of the Ar laser was used for EGFP excitation (to avoid any direct excitation of Cy3.5) and the 543 nm line of the He-Ne laser was used for Cy3.5 excitation. Acceptorphotobleaching experiments were performed using the acceptorphotobleaching software (Leica Microsystems, Nanterre, France). This software measures the fluorescence intensities of the donor and the acceptor, before and after acceptor photobleaching, in a given ROI, chosen at the plasma membrane of a cell. The ROIs were chosen to cover the whole membrane area of the cells and were homogeneous in size and fluorescence. Photobleaching of Cy3.5 was performed using the 543 nm laser at 100% power for 45 s. Photobleaching of the acceptor (PA) was calculated with the equation: PA = (I Abefore − I Aafter )/(I Abefore )
where I Abefore and I Aafter are the intensities of the acceptor before and after photobleaching. Only ROIs with an acceptor photobleaching higher than 20% were considered. The FRET signal was calculated as the rise in donor fluorescence with the equation:
where I Dbefore and I Dafter are the intensities of the donor before and after photobleaching of the acceptor.
Anisotropy experiments
Before imaging (4 days), tsA201 cells were resuspended in 35-mm Wilco dishes. The following day, cells were transfected with 3 μg of cDNA encoding EGFP-hM 1 , by the calcium phosphate technique (Chen and Okayama, 1987) . The day before imaging, cells were incubated overnight at 30
• C in the presence or absence of an excess of MT7 (60 nM). Cells were observed with a laser-scanning confocal microscope (Leica TCS-NT with AOTF, Leica Microsystems, Nanterre, France) mounted on an inverted microscope controlled through the software and workstation supplied by the manufacturer. Images were collected using a 40 × oil-immersion objective (NA = 0.5-1), using a standard scanning mode format of 512 pixels × 512 pixels. The 488 nm line of the Ar/Kr laser was used for EGFP excitation. A 530 + − 15 nm band-pass filter was used to collect the EGFP fluorescence which was split with a 50/50 mirror into two channels, each equipped with a polarized filter. The first channel selected the emitted light parallel to the incident light to generate the Ipar image. The second channel selected the emitted light perpendicular to the incident light to generate the Iper image. (The detectors of the two channels were initially equilibrated.) The intensity of the fluorescence emission through each polarizer was used to calculate the anisotropy ratio (r) with the equation: r = (Ipar − Iper)/(Ipar + 2Iper) where Ipar is the parallel polarization component of emission intensity, and Iper is the perpendicular polarization component of emission intensity (Gautier et al., 2001; Lidke et al., 2003) . For each experiment, the isotropic reference is adjusted with fluorescein in water (3 μM) to adjust each detector. In this case, Ipar ≈ Iper and r = 0.008 and the correction with the G factor is not necessary, as it is close to 1.
BRET assays
For BRET saturation experiments, COS cells, at 50-70% confluence, were transiently co-transfected, using the calcium phosphate technique (Chen and Okayama, 1987) , with 0.1 μg of hM 1 -RLuc alone or with increasing quantities (0.03-12 μg) of EYFP-tagged hM 1 receptor, GABA B R2-YFP or soluble YFP. The total amount of DNA transfected in each well was completed with empty vector to reach the same quantity in all assays. Posttransfection (72 h), cells were scrapped and washed with PBS and resuspended in PBS/0.1% glucose. The level of expression of the different constructs is 0.53 and 0.39 pmol/mg of protein for the hM 1 -RLuc and hM 1 -EYFP respectively. Then, 100 000 intact cells, prepared as described above, were distributed in each well of a 96-well microplate (white Costar plates, Corning). Coelenterazine h substrate (Interchim) was added at a final concentration of 5 μM and the BRET signal was measured with a Victor2 (Perkin Elmer) by using appropriate band-pass filters. The net BRET signal was defined as:
Net BRET = (emission at 510-560 nm)/(emission at 435-485 nm) − background where the background corresponds to (emission at 510-560 nm)/(emission at 435-485 nm) for the receptor-RLuc construct expressed alone in the same experiments. The absolute expression of EYFP and RLuc were measured on either clearbottomed or white opaque 96-well microplates respectively by using a Flexstation II (Molecular Devices) in fluorescence or luminescence (after addition of coelenterazine h) mode. Total fluorescence values were divided by the background determined in wells containing untransfected cells. The background values for the luminescence were negligible. To assess the effect of MT7, NMS or ACh, a saturating concentration of each ligand was added and incubated at 37
• C for 2 h before addition of coelenterazine h. These experiments were performed at least three times in duplicate.
Data analysis
The affinities of the orthosteric NMS in inhibiting the binding of [3H]NMS, expressed as pK i, , were calculated from the IC 50 values by applying the Cheng-Prussoff correction. The affinities of the allosteric MT7 in inhibiting the binding of [3H]NMS, expressed as pK x , was calculated using the ternarycomplex equation described previously (Lazareno and Birdsall, 1995; Fruchart-Gaillard et al., 2006) . All statistical calculations were performed using GraphPad Prism, version 5.00.
